U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

Hydroxypioglitazone (M-IV) is an active metabolite of the peroxisome proliferator-activated receptor γ (PPARγ) agonist pioglitazone. Experiments in vitro have shown that hydroxypioglitazone was more efficient than the parent drug in stimulating lipid synthesis.

Approval Year

Unknown
109281
PubMed

PubMed

TitleDatePubMed
Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
1996 Dec 20
Development and validation of highly selective and robust method for simultaneous estimation of pioglitazone, hydroxypioglitazone and metformin in human plasma by LC-MS/MS: application to a pharmacokinetic study.
2013 Jul 1
A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study.
2014 Oct 15
Substance Class
Concept
Record UNII
WN9K42SAM6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LERIGLITAZONE HYDROCHLORIDE
USAN  
Official Name English
ALL-AMBO-5-((4-(2-(5-(1-HYDROXYETHYL)PYRIDIN-2-YL)ETHOXY)PHENYL)METHYL)-1,3-THIAZOLE-2,4(3H,5H)-DIONE HYDROCLORIDE (1:1)
Common Name English
LERIGLITAZONE HYDROCHLORIDE [USAN]
Common Name English
2,4-THIAZOLIDINEDIONE, 5-((4-(2-(5-(1-HYDROXYETHYL)-2-PYRIDINYL)ETHOXY)PHENYL)METHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
2,4-THIAZOLIDINEDIONE, 5-((4-(2-(5-(1-HYDROXYETHYL)-2-PYRIDINYL)ETHOXY)PHENYL)METHYL)-, MONOHYDROCHLORIDE
Systematic Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/16/1770
Created by admin on Sat Jun 26 03:38:57 UTC 2021 , Edited by admin on Sat Jun 26 03:38:57 UTC 2021
Code System Code Type Description
CAS
146062-46-6
Created by admin on Sat Jun 26 03:38:57 UTC 2021 , Edited by admin on Sat Jun 26 03:38:57 UTC 2021
PRIMARY
EVMPD
SUB196366
Created by admin on Sat Jun 26 03:38:57 UTC 2021 , Edited by admin on Sat Jun 26 03:38:57 UTC 2021
PRIMARY
PUBCHEM
86748889
Created by admin on Sat Jun 26 03:38:57 UTC 2021 , Edited by admin on Sat Jun 26 03:38:57 UTC 2021
PRIMARY
NCI_THESAURUS
C174935
Created by admin on Sat Jun 26 03:38:57 UTC 2021 , Edited by admin on Sat Jun 26 03:38:57 UTC 2021
PRIMARY
FDA UNII
WN9K42SAM6
Created by admin on Sat Jun 26 03:38:57 UTC 2021 , Edited by admin on Sat Jun 26 03:38:57 UTC 2021
PRIMARY
This is a non-substance concept
Related Record Type Details
Structure of LERIGLITAZONE
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of LERIGLITAZONE
ACTIVE MOIETY
This is a non-substance concept
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966